Trial intelligence / Profile preview

CBD Roll-on in Primary Total Knee Arthroplasty

NCT04585230Unknown

Sponsor
Rothman Orthopaedics
Start
Oct 2020
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of cannabidiol in postoperative pain (4 arms), sponsored by Rothman Orthopaedics. Primary endpoints: Postoperative change in pain at 14 days and Change in the need for opiates at 14 days. Status: unknown.

02

Drugs

cannabidiol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04585230.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04585230.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call